BioMerieux Recalls ETEST Ciprofloxacin CI 32 Foam Due to Stability Issues
BioMerieux SA is recalling ETEST Ciprofloxacin CI 32 Foam products because their shelf-life claims are not supported by internal testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a stability issue with no reported illnesses or injuries, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
BioMerieux SA is recalling specific lots of ETEST Ciprofloxacin CI 32 Foam products. The recall was initiated because the current shelf-life claims for these products are not supported by internal testing. The affected products are used to determine the antimicrobial susceptibility of various bacteria.
The recall covers products distributed worldwide, including the United States and numerous foreign countries. Specific lot numbers are identified in the recall documentation. No illnesses or injuries have been reported in connection with this recall.
Healthcare facilities and laboratories should stop using the affected lots and contact BioMerieux SA for further instructions or returns.
The recalled product
- Product
- Ciprofloxacin CI 32 Foam packaging, Product Name: ETEST Ciprofloxacin CI 0.002-32. ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria such as Enterobacteriaceae, Pseudomonas, Staphylococcus and E
- Manufacturer
- BioMerieux SA
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Reference no. 508650
- Lot #1001060450
- 1001154650
- 1001212890
- 1001264540
- 1001319180
- 1001390080
- 1001390440
- 1001409510
- 1001409520
- 1001441760
- 1001540660
- 1001589490
- 1001621240 & 1001656460
- Reference no. 508658
- Lot #1001093880
- 1001154820
- 1001265110
- 1001319480
- 1001390570
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux PREVI Color Gram Reagents Recalled Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · product stability
See all →- ModerateMoxifloxacin Ophthalmic Solution Recalled Due to Manufacturing Quality Deviation
FDA (Drugs) · 2023-01-18
- ModerateFDA Recalls MIOSTAT Carbachol Solution Nationwide for Temperature Abuse
FDA (Drugs) · 2022-06-15
- HighDrug recall: Thrombin JMI injection kits due to manufacturing temperature deviation
FDA (Drugs) · 2022-06-15
- SevereSandoz Enoxaparin Sodium Injection Recalled Due to Temperature Excursion
FDA (Drugs) · 2021-12-08
- ModerateLoratadine-D Extended-Release Tablets Recalled for Failed Moisture Limits
FDA (Drugs) · 2021-11-03